Durrani AF - Search Results

1

Conversion to faricimab after prior anti-vascular endothelial growth factor therapy for persistent diabetic macular oedema.

Durrani AF, Momenaei B, Wakabayashi T, Vemula S, Pandit SA, Hsu J, Ho AC, Spirn MJ, Klufas MA, Garg SJ, Vander JF, Regillo CD, Chiang A, Kuriyan AE, Yonekawa Y. Durrani AF, et al. Br J Ophthalmol. 2024 Aug 22;108(9):1257-1262. doi: 10.1136/bjo-2023-324394. Br J Ophthalmol. 2024. PMID: 38346854

2

Long-Term Stability, Sterility, And Cost-Effectiveness of 0.05% Chlorhexidine Gluconate as Antisepsis for Intravitreal Injection.

Durrani AF, Momenaei B, Soni V, Tennant M, Hsu J, Vander J, Spirn M, Kang EY, Hwang YS, Kaushal G, Garg SJ. Durrani AF, et al. J Ocul Pharmacol Ther. 2024 Nov;40(9):581-587. doi: 10.1089/jop.2024.0071. Epub 2024 Aug 22. J Ocul Pharmacol Ther. 2024. PMID: 39169875

3

Microbiological evaluation of corneal and contact lens cultures in contact lens-associated bacterial keratitis.

Mukhtar S, Atta S, Durrani A, Perera C, Kowalski R, Jhanji V. Mukhtar S, et al. Br J Ophthalmol. 2022 May;106(5):600-604. doi: 10.1136/bjophthalmol-2020-317832. Epub 2020 Dec 23. Br J Ophthalmol. 2022. PMID: 33361442

4

Retinal Detachments after Open-Globe Injury: Risk Factors and Outcomes.

Sinha AK, Durrani AF, Li KX, Zhou Y, Musch DC, Zacks DN, Huvard MJ. Sinha AK, et al. Among authors: durrani af. Ophthalmol Retina. 2024 Apr;8(4):340-349. doi: 10.1016/j.oret.2023.10.008. Epub 2023 Oct 14. Ophthalmol Retina. 2024. PMID: 37844658

5

Ultrathin Descemet stripping automated endothelial keratoplasty.

Durrani AF, Faith SC, Jhanji V. Durrani AF, et al. Curr Opin Ophthalmol. 2019 Jul;30(4):264-270. doi: 10.1097/ICU.0000000000000575. Curr Opin Ophthalmol. 2019. PMID: 31033735 Review.

6

Risk Factors for Enucleation Following Open Globe Injury: A 17-Year Experience.

Toiv A, Durrani AF, Zhou Y, Zhao PY, Musch DC, Huvard MJ, Zacks DN. Toiv A, et al. Among authors: durrani af. Clin Ophthalmol. 2022 Oct 10;16:3339-3350. doi: 10.2147/OPTH.S377137. eCollection 2022. Clin Ophthalmol. 2022. PMID: 36237492 Free PMC article.

7

Moraxella Keratitis: Analysis of Risk Factors, Clinical Characteristics, Management, and Treatment Outcomes.

Durrani AF, Faith SC, Kowalski RP, Yu M, Romanowski E, Shanks R, Dhaliwal D, Jhanji V. Durrani AF, et al. Am J Ophthalmol. 2019 Jan;197:17-22. doi: 10.1016/j.ajo.2018.08.055. Epub 2018 Sep 8. Am J Ophthalmol. 2019. PMID: 30201340

8

Methicillin-Resistant Staphylococcus aureus Keratitis: Initial Treatment, Risk Factors, Clinical Features, and Treatment Outcomes.

Durrani AF, Atta S, Bhat AK, Mammen A, Dhaliwal D, Kowalski RP, Jhanji V. Durrani AF, et al. Am J Ophthalmol. 2020 Jun;214:119-126. doi: 10.1016/j.ajo.2020.03.017. Epub 2020 Mar 21. Am J Ophthalmol. 2020. PMID: 32209347

9

Large Internal Limiting Membrane Tears: Prevalence, Clinical Characteristics, and Surgical Utility.

Durrani AF, Hyde RA, Johnson MW. Durrani AF, et al. Am J Ophthalmol. 2023 Jan;245:115-125. doi: 10.1016/j.ajo.2022.09.007. Epub 2022 Oct 8. Am J Ophthalmol. 2023. PMID: 36216160 Review.

10

Risk Factors for Endophthalmitis Following Open Globe Injuries: A 17-Year Analysis.

Durrani AF, Zhao PY, Zhou Y, Huvard M, Azzouz L, Keil JM, Armenti ST, Dedania VS, Musch DC, Zacks DN. Durrani AF, et al. Clin Ophthalmol. 2021 May 18;15:2077-2087. doi: 10.2147/OPTH.S307718. eCollection 2021. Clin Ophthalmol. 2021. PMID: 34040343 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters